2021
DOI: 10.1073/pnas.2017148118
|View full text |Cite
|
Sign up to set email alerts
|

Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma

Abstract: Sex can be an important determinant of cancer phenotype, and exploring sex-biased tumor biology holds promise for identifying novel therapeutic targets and new approaches to cancer treatment. In an established isogenic murine model of glioblastoma (GBM), we discovered correlated transcriptome-wide sex differences in gene expression, H3K27ac marks, large Brd4-bound enhancer usage, and Brd4 localization to Myc and p53 genomic binding sites. These sex-biased gene expression patterns were also evident in human gli… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
27
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 31 publications
(29 citation statements)
references
References 83 publications
1
27
0
Order By: Relevance
“…Importantly, region-specific differences in response to (+)-JQ1 have been identified in the rodent brain, particularly in the context of dendritic spine density, suggesting brain cell type may be a major determining factor in the expression of these phenotypes (Wang et al, 2021b). Moreover, a recent study found sex divergent effects of Brd4 on cellular and transcriptional phenotypes in both human and mouse (Kfoury et al, 2021), further supporting the hypothesis that the impacts of BET inhibition are highly context dependent.…”
Section: Resultsmentioning
confidence: 53%
“…Importantly, region-specific differences in response to (+)-JQ1 have been identified in the rodent brain, particularly in the context of dendritic spine density, suggesting brain cell type may be a major determining factor in the expression of these phenotypes (Wang et al, 2021b). Moreover, a recent study found sex divergent effects of Brd4 on cellular and transcriptional phenotypes in both human and mouse (Kfoury et al, 2021), further supporting the hypothesis that the impacts of BET inhibition are highly context dependent.…”
Section: Resultsmentioning
confidence: 53%
“…This study is not the first study providing evidence that novel anti-cancer therapeutics currently in clinical trials might have sex-specific effects. It was recently reported that clinically utilized bromodomain inhibitors could produce sex-specific responses (Kfoury et al, 2021). Together, these studies emphasize the importance of including sex as a variable in basic research and clinical settings.…”
Section: Discussionmentioning
confidence: 86%
“…Sex differences in transcriptional processes related to membrane ion transport, excitability and interaction with drugs (7), as well as in chromatin regulation and epigenetic influences (21,65) have been previously reported for various organs. In the heart, the consequences of such sex differences may be of prime importance when developing and testing new drug compounds, including HDAC inhibitors.…”
Section: Discussionmentioning
confidence: 99%